HiPay Group SA (LON:0RA7)

Market Cap	53.94M
Revenue (ttm)	61.44M
Net Income (ttm)	4.83M
Shares Out	n/a
EPS (ttm)	0.97
PE Ratio	11.18
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	107
Average Volume	240
Open	9.82
Previous Close	9.66
Day's Range	9.82 - 10.45
52-Week Range	5.05 - 12.15
Beta	1.56
RSI	44.24
Earnings Date	Sep 16, 2025

About Verve Therapeutics

HiPay Group SA provides augmented payment solutions in France and rest of Europe. The company offers payment management solution, a customized management interface to explore data and analyze business; HiPay Sentinel, a fraud protection solution that protects from fraud attempts and adapts to business activity; payment methods, such as PAX terminals, deferred payment (Buy Now, Pay Later), and SaaS platforms; conversion optimization solutions; and HiPay Intelligence, a data analysis solution for optimizing data to gain a more granular understand...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2015
• Employees: 218
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RA7

Financial Performance

In 2024, HiPay Group's revenue was 74.30 million, an increase of 13.46% compared to the previous year's 65.48 million. Earnings were 5.84 million, an increase of 169.39%.